Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF

Yutaka Fujita1, Shoichi Maruyama, Hiroshi Kogo

  • 1Division of Clinical Immunology, Department of Internal Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan. fyutaka@med.nagoya-u.ac.jp

Kidney International
|October 22, 2004
PubMed
Abstract

Insights

Overexpressing caveolin-1 in mesangial cells inhibits the MAP kinase pathway and cell proliferation. This suggests caveolin-1 gene therapy could treat mesangioproliferative nephritis by blocking growth factors.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Renal Disease Research

Background:

  • Caveolin-1 is a key protein in caveolae, regulating cellular signaling.
  • Mesangial cells, crucial in renal function, possess abundant caveolae.
  • Modulating caveolin-1 levels may control mesangial cell proliferation, a factor in kidney diseases.

Purpose of the Study:

  • To investigate the effect of caveolin-1 on the Raf-MEK-MAP kinase pathway.
  • To determine caveolin-1's impact on mesangial cell proliferation stimulated by growth factors.
  • To explore caveolin-1 as a potential therapeutic target for renal diseases.

Main Methods:

  • Transfection of caveolin-1 cDNA into rat primary mesangial cells and MES13 cells.
  • Analysis of Raf-extracellular signal-regulated protein kinase (ERK) kinase (MEK)-mitogen-activated protein (MAP) kinase pathway activation via immunofluorescence and Western blot.
  • Assessment of cell proliferation in response to basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF).

Main Results:

  • Overexpression of caveolin-1 suppressed bFGF- and PDGF-induced activation of Raf-1, MEK-1/2, and MAP kinase.
  • Caveolin-1 overexpression inhibited mesangial cell proliferation stimulated by bFGF and PDGF.
  • The inhibitory effect was specific to the Raf-MEK-MAP kinase pathway, as Smad2 activation by TGF-beta was unaffected.

Conclusions:

  • Caveolin-1 overexpression in mesangial cells effectively suppresses MAP kinase activation and cell proliferation.
  • bFGF and PDGF are key cytokines in mesangioproliferative nephritis.
  • Introducing a caveolin-1 expression vector presents a potential therapeutic strategy for mesangioproliferative nephritis.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...